News
News

The latest updates from AFAR.

Grantee in the News: Ozioma Okonkwo Studies Exercise and Alzheimer’s Related Biomarkers

Dec 22
2014

Grantee in the News: Ozioma Okonkwo Studies Exercise and Alzheimer’s Related Biomarkers

On December 16th, The Washington Post reported on a study by 2013 Beeson Scholar, Ozioma Okonkwo, PhD.  Dr. Okonkwo’s research uniquely looks at exercise’s effect on the biomarkers related to Alzheimer’s disease.  His team found that late-middle aged people who exercised at least five times a week had a lower accumulation of “beta amyloid plaque,” the protein that builds up in the brains of people with Alzheimer’s.  Read more about the study’s findings here. Ozioma Okonkwo, PhD, is an Assistant Professor of Medicine at the University…


View MoreREAD MORE


Grantees in the News: 2014 Highlights

Dec 19
2014

Grantees in the News: 2014 Highlights

In 2014, over 45 AFAR Grantees, both past and present, were featured in 28 popular and scientific publications including 10 mentions in The New York Times, 4 appearances in The Washington Post, and publication in Cell Reports, Science, and Scientific American.    Peruse our full list of grantee news items from the past year here or check out the these highlights from 2014 below.   A March 7 Boston Globe article announced 2003 Beeson Award winner Reisa Sperling, MD as the recipient of the largest grant ever given by the Alzheimer’s Association: the $8 million grant will expand research on…


View MoreREAD MORE


Grantee in the News: Collin Ewald’s Research Explores Collagen and Longevity

Dec 18
2014

Grantee in the News: Collin Ewald’s Research Explores Collagen and Longevity

On December 15, Medical Press reported on research co-authored by 2013 Ellison Postdoctoral Fellow Collin Ewald, PhD on longevity interventions in microscopic worms. This study was originally published in the journal Nature.  Dr. Ewald and his collaborators tested interventions that were previously proven to boost longevity on C. elegans worms. Their tests showed that all of the interventions helped to increase collagen production and other proteins that support the structural integrity of tissues, organs, and bones.  Found in both C. elegans and humans, collagen helps to give tissue elasticity and strength.  The authors of this study believe that this…


View MoreREAD MORE


Grantee in the News: Reisa Sperling On the Need for More African Americans in Clinical Trials

Dec 2
2014

Grantee in the News: Reisa Sperling On the Need for More African Americans in Clinical Trials

In a November 23, 2014 article, The Washington Post explored how African Americans are almost twice as likely as Caucasians to develop Alzheimer’s disease yet are less likely to participate in clinical trials. Surveying the social and historic relationship between communities of color and clinical trials, the Post article features the efforts of 2003 AFAR Beeson Scholar Dr. Reisa Sperling, one of the nation’s premier Alzheimer’s researchers. Dr. Sperling is actively working to engage minorities in her 60-site study on whether regular transfusions of an antibody can help stop the events that result in memory loss…


View MoreREAD MORE


Grantee in the News: Domenico Pratico Finds Brain Receptor Cell Could Be Target for Alzheimer's Treatment

Nov 24
2014

Grantee in the News: Domenico Pratico Finds Brain Receptor Cell Could Be Target for Alzheimer's Treatment

On November 18, 2014 FoxNews.com reported on findings from 1997 AFAR Award recipient Domenico Pratico, M.D.’s study, originally published in the journal Neurobiology of Aging.  After studying the effects of free radicals on thromboxane reception (TP) in the brain, Dr. Pratico’s team findings suggest that targeting the TP may prove effective in treatment for Alzheimer’s disease. Read FoxNews.com’s full story on Dr. Pratico’s research here. Dr. Domenico Pratico is a Professor at Temple University School of Medicine. For more about Alzheimer’s disease research, visit our…


View MoreREAD MORE




BACK TO TOPBACK TO TOP